Bank of America’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
VCM
6CM
KGAMU
WPM
RC
QOP
Bank of America's CDLX Position: Q1 2026 in Review
Bank of America reduced its Cardlytics (CDLX) stake by 98% in Q1 2026, selling an estimated $1.39M and leaving 3,546 shares worth $37.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5626.
Bank of America first reported a position in CDLX in Q1 2018 and has held it in 33 quarters since. The position peaked at $24.2M in Q4 2019. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.
- Bank of America held 3,546 shares of Cardlytics worth $37.2K as of Q1 2026.
- Bank of America sold 142,458 Cardlytics shares in Q1 2026, an estimated $1.39M.
- Cardlytics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5626 holding.
- Bank of America first reported a position in Cardlytics in Q1 2018 and has held it in 33 quarters since.
- Bank of America's Cardlytics position peaked at $24.2M in Q4 2019.
- 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.